<DOC>
	<DOCNO>NCT02961478</DOCNO>
	<brief_summary>IOXSOR study 's purpose determine frequency non resolutive renal failure ( estimate clearance iohexol ) end stay ICU patient acute renal failure episode .</brief_summary>
	<brief_title>Measurement Iohexol Plasma Clearance Patients Leaving ICU After Acute Renal Failure</brief_title>
	<detailed_description />
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Acute Kidney Injury</mesh_term>
	<criteria>ICU stay &gt; 7 day Having present stay renal failure stage 2 3 Kidney Disease Improving Global Outcomes ( KDIGO ) Steady improvement renal function ICU discharge : Creatinine ICU discharge &lt; 110 µmol / L woman , &lt; 130 µmol / L men No recourse extra renal purification Change creatinine level ( ΔCréatinine ) less 20 % two measure space 24 hour within 48 hour precede discharge Expected discharge ICU within 48 hour : Glasgow score &gt; 13 Lack mechanical ventilation except home Noninvasive Mechanical Ventilation ( NiMV ) Lack use catecholamine No contraindication discharge accord physician charge patient Informed consent sign patient , possible person trust family present . Written consent patient obtain soon deem possible . Iohexol administration within 48 hour precede potential inclusion ( image examination Xray contrast medium injection ) Iohexol administration plan within 24 hour potential inclusion study Known medical history immediate allergic delay skin allergic reaction injection iodinate contrast material serious doubt medical history Patient receive extra renal purification ICU discharge Chronic renal disease know ( creatinine &gt; 110 µmol / L woman , &gt; 130 µmol / L men ) creatinine clearance estimate less 60 mL / min Pregnancy breastfeed woman Patient guardianship safeguard justice know time inclusion Patient limitation care Person affiliate beneficiary social security scheme</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>